John P. Berdahl, MD, a surgeon at Vance Thompson Vision and a professor at the University of South Dakota, spoke on the lens ...

Early pegcetacoplan treatment results in significantly greater tissue preservation compared to delayed treatment, emphasizing ...

Pickleball's popularity surged, with a 311% increase in players since 2020, reaching 19.8 million in 2024. A cross-sectional ...

Ken Beckman, MD, FACS, is a corneal specialist and clinical assistant professor at The Ohio State University. At the 2025 ...

DAVIO-2 for wet AMD and VERONA for DME. In the DAVIO-2 trial, patients previously treated with approximately 10 injections in ...

In the Phase 2 TEASE 2 trial, gildeuretinol was well tolerated and showed promising trends in slowing ellipsoid zone loss and preserving low-luminance visual acuity in patients with Stargardt disease.

The American Academy of Ophthalmology (AAO) is hosting its annual scientific meeting in Orlando, Florida from October 17 ...

The 18-month extension of the GATHER2 trial indicated continued benefit for patients receiving avacincaptad pegol, with ...

A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, ...

The study analyzed real-world treatment patterns and safety of avacincaptad pegol (ACP) for geographic atrophy using the IRIS ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...